In vitro and in silico analyses reveal Lablab purpureus fractions exhibit antioxidant and anticancer activity, suggesting potential uses in cancer treatment.
This study identified LPMMF 1.5 as a bioactive fraction with significant antioxidant and anticancer activity. Picroside-1 emerged as a key compound, exhibiting strong affinity and stable interactions with cancer-relevant targets. These findings support its potential development as a plant-derived anticancer lead candidate.
No takes yet. Share an insight, caveat, or question.
Bhat et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: